Fresh2 Group Limited (FRES)

0.4399 +0.0264 (+6.38%) As of 01:46PM EDT. Market open.

Fresh2 Group Limited

650 5th Ave
Suite 2416
New York, NY 10019-6108
United States

https://fresh2.co

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 75

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Haohan Xu	Chairman of the Board & CEO	N/A	N/A	1995
Dr. He Yu	Co-Founder & Chief Scientist	N/A	N/A	1958
Ms. Xiaoyu Li	Director & CFO	N/A	N/A	1989
Mr. Weidong Dai	China President	N/A	N/A	1961
Dr. Sunil Pandit	U.S. Chief Executive Officer	N/A	N/A	N/A
Mr. Yidong Hu	Chief Strategy Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Corporate governance

Fresh2 Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.